CLC
Galectin-10
Also known as: Gal-10, LEG10_HUMAN, LGALS10, MGC149659
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q05315
- Gene
- CLC
- Ensembl
- ENSG00000105205
- Chromosome
- 19
- Canonical length
- 142 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. The protein encoded by this gene is a lysophospholipase expressed in eosinophils and basophils. It hydrolyzes lysophosphatidylcholine to glycerophosphocholine and a free fatty acid. This protein may possess carbohydrate or IgE-binding activities. It is both structurally and functionally related to the galectin family of beta-galactoside binding proteins. It may be associated with inflammation and some myeloid leukemias. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
142 residues, UniProt reviewed canonical sequence.
>Q05315|CLC
1 MSLLPVPYTE AASLSTGSTV TIKGRPLACF LNEPYLQVDF HTEMKEESDI VFHFQVCFGR
61 RVVMNSREYG AWKQQVESKN MPFQDGQEFE LSISVLPDKY QVMVNGQSSY TFDHRIKPEA
121 VKMVQVWRDI SLTKFNVSYL KRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 427 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 427 nTPM
- small intestine: 39 nTPM
- appendix: 28 nTPM
- duodenum: 24 nTPM
- smooth muscle: 23 nTPM
- urinary bladder: 23 nTPM
Single-cell type
- neutrophil progenitors: 191 nCPM
- monocyte progenitors: 36 nCPM
- neutrophils: 35 nCPM
- mast cells: 15 nCPM
- tuft cells: 12 nCPM
- hematopoietic stem cells: 6.3 nCPM
Immune cell
- basophil: 28,920 nTPM
- eosinophil: 21,549 nTPM
- total PBMC: 101 nTPM
- neutrophil: 81 nTPM
- non-classical monocyte: 13 nTPM
- intermediate monocyte: 11 nTPM
Brain region
- hypothalamus: 1.7 nTPM
- cerebellum: 0.3 nTPM
- pons: 0.2 nTPM
- cerebral cortex: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
- midbrain: 0.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CLC.
Disease | ImmuneIEDB
Conditions an epitope on CLC was assayed in.
- rheumatoid arthritis B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.75
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.02
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- regulation of activated T cell proliferation
- regulation of T cell anergy
- regulation of T cell cytokine production
- T cell apoptotic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CLC in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLC as an antibody target. Whether an autoantibody or antibody against CLC could matter depends on whether native CLC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLC is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CLC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...